Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RALPH BOCCIA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1881663284
CMS profile
175674
Location
BETHESDA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$452,016.98

405 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Ownership and Investment Interests

CMS also publishes Ownership and Investment Interests as a separate dataset. This site does not currently mirror it, and no ownership figure is shown on this page. This provider appears in that dataset.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Celgene Corporation $113,768.43 51
Incyte Corporation $59,647.29 33
Janssen Biotech, Inc. $44,012.87 44
Amgen Inc. $28,223.79 18
AstraZeneca Pharmaceuticals LP $25,159.79 38
Taiho Oncology, Inc. $19,715.00 13
GENZYME CORPORATION $19,405.24 16
Puma Biotechnology, Inc. $18,048.56 17
Coherus Biosciences Inc. $13,113.41 10
E.R. Squibb & Sons, L.L.C. $12,315.14 14
Takeda Pharmaceuticals U.S.A., Inc. $11,091.52 8
Dova Pharmaceuticals $10,549.99 6
Rigel Pharmaceuticals, Inc. $9,975.28 13
Pharmacosmos Therapeutics Inc. $9,647.74 4
Regeneron Healthcare Solutions, Inc. $7,828.97 6
Blueprint Medicines Corporation $7,690.97 10
Daiichi Sankyo Inc. $7,373.73 8
Epizyme, Inc., $5,791.24 4
Karyopharm Therapeutics Inc. $5,757.21 5
GlaxoSmithKline, LLC. $4,870.72 3
Grifols Shared Services North America, Inc. $4,210.00 2
Genentech USA, Inc. $3,164.39 3
AbbVie Inc. $3,054.50 3
Seagen Inc. $2,427.15 10
BeiGene USA, Inc. $1,682.56 4
Jazz Pharmaceuticals Inc. $1,350.00 1
Verastem, Inc. $990.00 1
Eisai Inc. $172.99 9
Pharmacyclics LLC, An AbbVie Company $138.88 7
Merck Sharp & Dohme Corporation $121.74 8
Dendreon Pharmaceuticals LLC $101.46 5
Johnson & Johnson Health Care Systems Inc. $72.20 1
Novartis Pharmaceuticals Corporation $66.85 3
PFIZER INC. $61.48 4
Exelixis Inc. $55.78 3
EMD Serono, Inc. $51.86 2
Global Blood Therapeutics, Inc. $43.67 2
Alexion Pharmaceuticals, Inc. $33.41 2
Bayer HealthCare Pharmaceuticals Inc. $32.84 2
Ipsen Biopharmaceuticals, Inc $32.14 2
Agios Pharmaceuticals, Inc. $27.97 2
Mylan Institutional Inc. $20.22 1
ASD Specialty Healthcare, LLC $19.55 1
Sandoz Inc. $19.07 1
EUSA Pharma (US) LLC $16.83 1
Janssen Pharmaceuticals, Inc $16.62 1
Foundation Medicine, Inc. $16.08 1
Secura Bio, Inc. $15.62 1
Kite Pharma, Inc. $14.23 1

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

405 matching records · $452,016.98 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 405 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 405.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $450.0010/12/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736421541 CMS
Janssen Biotech, Inc. $18.5410/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026719364087 CMS
Taiho Oncology, Inc. $1,565.0010/08/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724401223 CMS
AstraZeneca Pharmaceuticals LP $2,055.0010/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735760989 CMS
Grifols Shared Services North America, Inc. $4,000.0010/07/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750401795 CMS
Grifols Shared Services North America, Inc. $210.0010/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750401797 CMS
Incyte Corporation $1,250.0010/07/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026745803055 CMS
Janssen Biotech, Inc. $22.7010/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026719364099 CMS
GENZYME CORPORATION $1,300.0010/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744154155 CMS
Incyte Corporation $2,460.0010/06/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026745803075 CMS
Merck Sharp & Dohme Corporation $14.3110/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747781821 CMS
Merck Sharp & Dohme Corporation $13.5910/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747766985 CMS
Celgene Corporation $4,500.0010/02/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727960365 CMS
Celgene Corporation $4,056.0010/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727960381 CMS
GENZYME CORPORATION $16.0910/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744154127 CMS
Exelixis Inc. $22.0009/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026737177437 CMS
Incyte Corporation $2,460.0009/30/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026745803063 CMS
Incyte Corporation $2,460.0009/30/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026745803067 CMS
AstraZeneca Pharmaceuticals LP $1,350.0009/29/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736033673 CMS
Pharmacosmos Therapeutics Inc. $1,125.0009/29/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736868962 CMS
AstraZeneca Pharmaceuticals LP $18.7609/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736177573 CMS
Blueprint Medicines Corporation $990.0009/25/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750716009 CMS
Genentech USA, Inc. $1,160.0009/25/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026743085617 CMS
GlaxoSmithKline, LLC. $29.2209/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738549857 CMS
Regeneron Healthcare Solutions, Inc. $2,620.0009/25/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724414469 CMS
Celgene Corporation $2,625.0009/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727960403 CMS
Celgene Corporation $2,625.0009/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727960415 CMS
Celgene Corporation $20.7509/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727960389 CMS
Celgene Corporation $2,625.0009/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727960411 CMS
Taiho Oncology, Inc. $1,565.0009/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724401267 CMS
Blueprint Medicines Corporation $495.0009/22/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750716013 CMS
Pharmacyclics LLC, An AbbVie Company $28.9109/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026725673219 CMS
Janssen Biotech, Inc. $1,200.0009/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026719364075 CMS
Puma Biotechnology, Inc. $1,000.0009/18/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026750539437 CMS
Amgen Inc. $15.9009/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741270275 CMS
Amgen Inc. $437.2509/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026741431337 CMS
Incyte Corporation $2,460.0009/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026745803059 CMS
Global Blood Therapeutics, Inc. $22.7509/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026742103975 CMS
Regeneron Healthcare Solutions, Inc. $1,300.0009/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724414465 CMS
Regeneron Healthcare Solutions, Inc. $1,300.0009/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026724414467 CMS
Seagen Inc. $13.7609/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026732449231 CMS
AbbVie Inc. $17.0009/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026721702667 CMS
AstraZeneca Pharmaceuticals LP $1,350.0009/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735861217 CMS
Celgene Corporation $24.2909/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727960307 CMS
Agios Pharmaceuticals, Inc. $15.5209/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751964851 CMS
Celgene Corporation $1,500.0009/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727960323 CMS
GENZYME CORPORATION $14.4209/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744154115 CMS
GENZYME CORPORATION $1,300.0009/08/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753386927 CMS
AstraZeneca Pharmaceuticals LP $1,370.0009/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736138135 CMS
AstraZeneca Pharmaceuticals LP $2,055.0009/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736153469 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $707,458.24 649
PY2020 $452,016.98 405
PY2021 $393,668.10 454
PY2022 $493,041.79 506
PY2023 $415,808.04 493
PY2024 $433,660.62 450
PY2025 $244,074.29 326

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
RALPH BOCCIA, NPI 1881663284. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1881663284.
APA 7
IndustryPayments. (2026). RALPH BOCCIA, NPI 1881663284 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1881663284
Bluebook
RALPH BOCCIA, NPI 1881663284, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1881663284.

Source: Centers for Medicare & Medicaid Services, Open Payments.